Time-Varying Risk for Breast Cancer Following Initiation of Glucose-Lowering Therapy in Women with Type 2 Diabetes: Exploring Detection Bias.

Canadian Journal of Diabetes(2017)

引用 3|浏览3
暂无评分
摘要
Our findings suggest that no detection bias exists for glucose-lowering therapies and breast cancer in this population.
更多
查看译文
关键词
breast cancer,cohort study,epidemiology,glucose-lowering therapies,type 2 diabetes
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要